Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition-Reference-Cited by-同舟云学术

Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition

Published:2017-06-12 Issue:9 Volume:56 Page:1566-1572
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Ibáñez Vodnizza Sebastián,Visman Ingrid M.,van Denderen Christiaan,Lems Willem F.,Jaime Francisca,Nurmohamed Michael T.,van der Horst-Bruinsma Irene E.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/56/9/1566/19540040/kex187.pdf

Reference48 articles.

1. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies;Ann Rheum Dis,2013

2. Male and female patients with axial spondyloarthritis experience disease activity, physical function and quality of life differently: results from the Groningen Leeuwarden Axial Spondyloarthritis cohort;Rheumatology,2015

3. Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis;RMD Open,2015

4. Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry;Ann Rheum Dis,2013

5. Drug survival of anti-tumour necrosis factor α therapy in spondyloarthropathies: results from the Spanish emAR II Study;Rheumatology,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of screening tools for sarcopenia in patients with axial spondyloarthritis;Scientific Reports;2024-06-22

2. Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy;Rheumatology;2024-03-20

3. Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study;RMD Open;2024-01

4. Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network;RMD Open;2023-12

5. Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis;Clinical Rheumatology;2023-09-27